Medpace Holdings, Inc. (MEDP): Share Repurchases
$917.39M
Year ended 2025-12-31
$299.34M
Trailing 12 months to 2026-06-30
+2.7%
3-year compound annual growth
+56.3%
5-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $917.39M | +440.1% | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $169.87M | +17.9% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $144.02M | -83.0% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $847.85M | n/m | 2025-02-11, From 2022-01-01 |
| 2021-12-31 | $62.10M | -36.8% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $98.27M | n/a | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $0 | n/a | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $0 | -100.0% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $155.58M | n/a | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $0 | n/a | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $0 | n/a | 2018-02-27, From 2015-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $917.39M | +440.1% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $360.67M | +202.6% |
| Incyte Corp (INCY) | 2025-12-31 | $0 | -100.0% |
| Icon PLC (ICLR) | 2025-12-31 | $750.00M | +50.0% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $1.24B | -7.9% |
| NRC Health (NRC) | 2025-12-31 | $20.18M | -34.8% |
| IB Acquisition Corp. (IBAC) | 2025-09-30 | $106.13M | n/a |
Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗